Your browser doesn't support javascript.
loading
Switching to an alternative recombinant erythropoietin agent in patients with myelodysplastic syndromes: a second honeymoon?
Fattizzo, Bruno; Rizzo, Lorenzo; Giannotta, Juri Alessandro; Mazzon, Federico; Cecchi, Nicola; Frangi, Claudia; Barcellini, Wilma; Riva, Marta.
Afiliação
  • Fattizzo B; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Rizzo L; Department of Oncology and Oncohematology, University of Milan, Milan, Italy.
  • Giannotta JA; Department of Hematology and Oncology, Niguarda Cancer Center, ASST Ospedale Niguarda, Milan, Italy.
  • Mazzon F; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
  • Cecchi N; Department of Hematology and Oncology, Niguarda Cancer Center, ASST Ospedale Niguarda, Milan, Italy.
  • Frangi C; Department of Oncology and Oncohematology, University of Milan, Milan, Italy.
  • Barcellini W; Department of Hematology and Oncology, Niguarda Cancer Center, ASST Ospedale Niguarda, Milan, Italy.
  • Riva M; Hematology Unit, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Br J Haematol ; 195(4): e147-e150, 2021 11.
Article em En | MEDLINE | ID: mdl-34312838
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Eritropoetina / Epoetina alfa / Darbepoetina alfa Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Síndromes Mielodisplásicas / Eritropoetina / Epoetina alfa / Darbepoetina alfa Idioma: En Ano de publicação: 2021 Tipo de documento: Article